Navigation Links
When prescribing antibiotics, doctors most often choose strongest types of drugs
Date:8/1/2013

(SALT LAKE CITY)When U.S. physicians prescribe antibiotics, more than 60 percent of the time they choose some of the strongest types of antibiotics, referred to as "broad spectrum," which are capable of killing multiple kinds of bacteria, University of Utah researchers show in a new study.

Unfortunately, in more than 25 percent of such prescriptions are useless because the infection stems from a virus, which cannot be treated with antibiotics. This overuse of antibiotics has a number of downsides, including that these types of drugs kill more of the "good" bacteria found in our bodies which may lead to more side effects and also contribute to the growth of antibiotic-resistant bacteria, according to Adam L. Hersh, M.D., Ph.D., an infectious disease expert, assistant professor of pediatrics at the University of Utah School of Medicine and senior author on a study published July 29, 2013, in the Journal of Antimicrobial Chemotherapy.

Discerning whether an infection is viral or bacterial can be tricky, according to Hersh, which probably accounts for much of the overuse of antibiotics. "It seems that the natural bias, when there is uncertainty about an infection's cause, is to err on the side of prescribing antibiotics," he says. "Our study found that the majority of prescriptions are for antibiotics that kill a wider range of bacteria, and that they are most likely to be given when they're not needed, such as in cases of viral infections."

The types of illnesses where doctors seem to choose stronger antibiotics include respiratory problems, skin infections and urinary tract infections, which in many cases would be better treated by other antibiotics that are less likely to cause resistance.

Hersh, Andrew T. Pavia, M.D., also an infectious disease expert and professor of pediatrics at the University of Utah, Lauri A. Hicks, D.O., a medical epidemiologist at the U.S. Centers for Disease Control and Prevention, and University of California, San Francisco, medical student Daniel J. Shapiro, conducted the study using a public database with information on ambulatory care visits at physician offices and hospital-based outpatient and emergency departments nationwide. Studying data from between 2007-2009, they identified a sample of 238,624 visits by patients 18 and older at those medical facilities and found that 61 percent of antibiotic prescriptions were for broad-spectrum drugs, such as Levaquin. Narrow-spectrum antibiotics, such as amoxicillin and doxycycline, comprised the remaining 39 percent of antibiotic prescriptions.

Based on the sample of 238,000-plus visits, the researchers estimate there was an average of 985 million annual ambulatory care visits for the 2007-2009 period, with antibiotics being prescribed in an estimated 101 million of those visits each year 62 million in which broad-spectrum antibiotics were prescribed and 39 million that resulted in narrow-spectrum antibiotics prescriptions.

While this study looked only at adult ambulatory care visits, the prescription pattern for children is similar, according to Hersh. "Many antibiotics prescribed for children are unnecessary, particularly for conditions caused by viruses, where antibiotics don't help at all," he says. "Even when an antibiotic is indicated, such as for strep throat or some ear infection, physicians often prescribe and antibiotic such as a Z-Pak, which can be less effective than amoxicillin."

Hicks emphasizes that antibiotic overuse among children and adults is a serious problem and a threat to everyone's health. "The biggest problem with using antibiotics when they're not needed is the development of antibiotic resistance, which is when bacteria survive by outsmarting the antibiotic," she says. "Common infections become difficult to treat, and when you really need an antibiotic, it may not work."

Uncertainty about the cause of an infection is one factor in the overuse of broad-spectrum antibiotics, but there are other influences too, according to Hersh. This includes a misperception by physicians that their patients expect an antibiotic if they take the time to see the doctor. But Hersh believes this second factor is changing, due in part to major efforts to educate people about the problems associated with overuse of antibiotics, such as CDC's "Get Smart: Know When Antibiotics Work" program.

"The public is increasingly aware of the downside and side effects of antibiotics," Hersh says. "Actually, when they see their doctor, most patients just want an explanation as to what's wrong and are open to considering why an antibiotic wouldn't be helpful."

He urges patients to play a larger role by asking their doctor two questions: Do I really need this antibiotic? And, is this antibiotic the best choice for my infection?

"Both doctors and patients have a role in ensuring the effectiveness of antibiotics is preserved by using them only when needed," Pavia says.


'/>"/>

Contact: Phil Sahm
phil.sahm@hsc.utah.edu
801-581-2517
University of Utah Health Sciences
Source:Eurekalert

Related medicine news :

1. Variations in antibiotic prescribing of acute rhinosinusitis in united states ambulatory settings
2. Rottenstein Law Group Notes Medical Journal Article Advising Doctors To Use Caution When Prescribing Zithromax and Other Antibiotics
3. Antibiotic Prescribing Rates Vary by Region: Report
4. SiliconMesa Partners with DrFirst to Add E-prescribing and Medication Adherence Functionality to SiliconMesa EHR
5. BU School of Medicine launches safe opioid prescribing education program for health care providers
6. Dr Jonathan Zaidan Opens State-of-the-Art Specialty Center, Women’s Excellence in Endometriosis, Featuring Electronic Medical Records and E-prescribing, near Pontiac, MI
7. Study: Electronic Prescribing Cuts Medication Errors
8. E-Prescribing Market is Growing at a CAGR of 26% & to Reach Worth $794 Million by 2017 - New Report by MarketsandMarkets
9. Overprescribing of opioids impacts patient safety and public health
10. PracticeFusion, DrFirst and Emdeon ranked as Top Electronic Prescribing Vendors Among Satisfied Clients, Black Book 2013 Survey
11. Electronic visits offer accurate diagnoses, may lead to overprescribing of antibiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: